Eisai
4523.T
#2008
Rank
โ‚น868.45 B
Marketcap
โ‚น3,081
Share price
-0.53%
Change (1 day)
15.70%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): โ‚น33.16 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.44 Billion. In 2025 the company made an earning of โ‚น39.57 Billion a decrease over its 2024 earnings that were of โ‚น49.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น33.16 B-16.18%
2025 โ‚น39.57 B-20.48%
2024 โ‚น49.76 B2.42%
2023 โ‚น48.59 B-2404.04%
2022 -โ‚น2.11 Billion-103.6%
2021 โ‚น58.64 B-39.81%
2020 โ‚น97.42 B7.44%
2019 โ‚น90.67 B17.22%
2018 โ‚น77.35 B86.16%
2017 โ‚น41.55 B-23.52%
2016 โ‚น54.33 B26.97%
2015 โ‚น42.79 B22.3%
2014 โ‚น34.99 B-46.07%
2013 โ‚น64.88 B-21.85%
2012 โ‚น83.02 B-20.59%
2011 โ‚น104.54 B-8.91%
2010 โ‚น114.78 B19.21%
2009 โ‚น96.28 B